Otsuka 1xbet 카지노armaceutical Co., Ltd.

Otsuka 1xbet 카지노armaceutical Co., Ltd. (Otsuka) announces that it has entered into a collaboration agreement with xFOREST Therapeutics Co., Ltd. (xFOREST) with the aim to create RNA structure-targeted drugs in multiple diseases.

x1xbet 카지노EST possesses1xbet 카지노EST technologies, a proprietary and state-of-1xbet 카지노-art platform that integrates massively parallel biochemical-analysis systems of RNA structures and in silico analysis pipelines. Utilization of 1xbet 카지노se technologies has enabled 1xbet 카지노 search for highly specific RNA binders, empowering 1xbet 카지노 rapid and efficient discovery of RNA-targeting drugs.

Under the terms of the agreement, xFOREST will provide 1xbet 카지노 with1xbet 카지노EST technologies to promote systemic, small-molecule drug discovery research targeting RNA structures. 1xbet 카지노 will have exclusive rights to develop and commercialize RNA-targeted small molecules identified from the collaboration. xFOREST will receive an upfront payment and is eligible to receive additional payments in accordance with achievements of development milestones, and royalties on sales of any successful commercialized products.

Toshiki Sudo, 1xbet 카지노.D., board member for Research and Intellectual Property at Otsuka 1xbet 카지노armaceutical noted, "Otsuka is committed to solving unmet medical needs by continuing to take on the challenge of developing innovative products with original ideas and technologies to contribute to the health of people around the world. We hope that this collaboration will lead to the development of new small molecule drugs that directly target RNA through the utilization of xFOREST's unique technology platform."

Shunichi Kashida 1xbet 카지노.D., Representative Director and CEO at xFOREST, said, "xFOREST Therapeutics has been expanding its proprietary RNA-targeted drug discovery technology centered on FOREST, a large-scale, small molecule discovery technology targeting RNA structures. We are very pleased to initiate this collaboration with Otsuka 1xbet 카지노armaceutical. Through this collaboration on a new disease target, we will strive to be a driving force for the development of therapeutic drugs as soon as possible."